简介:
Overview
This protocol outlines a cost-effective method for producing high-titer, research-grade AAV viral vectors using adherent HEK293 cells. The approach is designed for efficiency and high purity, making it suitable for preclinical studies in large animal models.
Key Study Components
Area of Science
- Gene therapy
- Viral vector production
- Cell culture techniques
Background
- AAV vectors are crucial for gene therapy applications.
- HEK293 cells are commonly used for AAV production.
- High titer and purity are essential for effective research outcomes.
- This method minimizes handling disruptions to cells.
Purpose of Study
- To provide a reliable protocol for AAV vector production.
- To enhance the efficiency of viral vector generation.
- To support research in gene therapy and related fields.
Methods Used
- Utilization of adherent HEK293 cells in cell culture chambers.
- Affinity chromatography for purification of AAV vectors.
- Collection of cells at 80% confluency for optimal yield.
- Time-efficient procedures to reduce cell handling.
Main Results
- Consistent yield of >1 x 1013 vector genomes/mL.
- High purity of produced AAV vectors.
- Protocol suitable for large animal studies.
- Adaptable for various AAV serotypes.
Conclusions
- This protocol significantly aids in the production of AAV vectors.
- It is a valuable tool for advancing gene therapy research.
- Potential for broader applications in viral vector production.
What are AAV vectors used for?
AAV vectors are primarily used in gene therapy to deliver genetic material into cells.
Why use HEK293 cells for AAV production?
HEK293 cells are efficient for producing high-titer AAV vectors due to their robust growth and transfection properties.
How does affinity chromatography purify AAV vectors?
Affinity chromatography separates AAV vectors based on their binding properties, resulting in high purity.
What is the significance of high titer in AAV production?
High titer ensures that sufficient viral vectors are available for effective research and therapeutic applications.
Can this protocol be adapted for other AAV serotypes?
Yes, the protocol can be modified for the production of various AAV serotypes that bind heparan sulfate.
Is this method time-efficient?
Yes, the protocol is designed to minimize handling and disruptions, making it time-efficient.